Literature DB >> 29167970

Independent association of bone mineral density and trabecular bone score to vertebral fracture in male subjects with chronic obstructive pulmonary disease.

R Watanabe1, N Tai1, J Hirano1, Y Ban1, D Inoue2, R Okazaki1.   

Abstract

Osteoporosis is a major comorbidity of chronic obstructive pulmonary disease (COPD), but the mechanism of bone fragility is unknown. We demonstrated that trabecular bone score, a parameter of bone quality, was associated with systemic inflammation and was a significant determinant of vertebral fracture independent of bone mineral density.
INTRODUCTION: COPD is a major cause of secondary osteoporosis. However, the mechanism of bone fragility is unclear. We previously reported that vertebral fracture was highly prevalent in male COPD patients. To obtain clues to the mechanism of COPD-associated osteoporosis, we attempted to identify determinants of prevalent vertebral fracture in this study.
METHODS: In this cross-sectional study, we recruited 61 COPD males and examined pulmonary function, vertebral fractures, bone mineral density (BMD), trabecular bone score (TBS), bone turnover markers, and inflammatory parameters. Determinants of the bone parameters were examined by multivariable analyses.
RESULTS: The prevalence of any and grade 2 or 3 fractures was 75.4 and 19.7%, respectively. Osteoporosis and osteopenia defined by BMD were present in 37.7 and 39.3%, respectively. TBS was significantly lower in higher Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages compared to GOLD 1. Multivariable logistic regression analysis revealed that both TBS and BMD were independent determinants of grade 2 or 3 vertebral fractures (OR = 0.271, 95%CI 0.083-0.888, p = 0.031; OR = 0.242, 95%CI 0.075-0.775, p = 0.017) after adjustment for age. Correlates of TBS included age, BMD, high-sensitivity C-reactive protein (hsCRP), pulmonary function parameters, parathyroid hormone, and Tracp-5b. In multivariable regression analysis, hsCRP was the only independent determinant of TBS besides age and BMD. In contrast, independent determinants of BMD included body mass index and, to a lesser extent, 25-hydroxyvitamin D.
CONCLUSION: Both BMD and TBS were independently associated with grade 2 or 3 vertebral fracture in COPD male subjects, involving distinct mechanisms. Systemic inflammation, as reflected by increased hsCRP levels, may be involved in deterioration of the trabecular microarchitecture in COPD-associated osteoporosis, whereas BMD decline is most strongly associated with weight loss.

Entities:  

Keywords:  Bone quality; C-reactive protein (CRP); Chronic obstructive pulmonary disease (COPD); Osteoporosis; Trabecular bone score (TBS)

Mesh:

Year:  2017        PMID: 29167970     DOI: 10.1007/s00198-017-4314-7

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  34 in total

1.  Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study.

Authors:  Didier Hans; Andrew L Goertzen; Marc-Antoine Krieg; William D Leslie
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

2.  Improving hip fractures outcomes for COPD patients.

Authors:  Elizabeth A Regan; Tiffany A Radcliff; William G Henderson; Diane C Cowper Ripley; Matthew L Maciejewski; W Bruce Vogel; Evelyn Hutt
Journal:  COPD       Date:  2012-12-28       Impact factor: 2.409

3.  The association of low bone mineral density with systemic inflammation in clinically stable COPD.

Authors:  Binmiao Liang; Yulin Feng
Journal:  Endocrine       Date:  2011-12-24       Impact factor: 3.633

4.  Skeletal microstructural abnormalities in postmenopausal women with chronic obstructive pulmonary disease.

Authors:  Carolina A M Kulak; Victoria C Borba; Vanda Jorgetti; Luciene M Dos Reis; Xiaowei S Liu; Donald B Kimmel; Jaime Kulak; Leda M Rabelo; Hua Zhou; X Edward Guo; John P Bilezikian; Cesar L Boguszewski; David W Dempster
Journal:  J Bone Miner Res       Date:  2010-09       Impact factor: 6.741

5.  Osteoporosis in men: the value of laboratory testing.

Authors:  C S Ryan; V I Petkov; R A Adler
Journal:  Osteoporos Int       Date:  2010-10-09       Impact factor: 4.507

6.  C-reactive protein, bone strength, and nine-year fracture risk: data from the Study of Women's Health Across the Nation (SWAN).

Authors:  Shinya Ishii; Jane A Cauley; Gail A Greendale; Carolyn J Crandall; Michelle E Danielson; Yasuyoshi Ouchi; Arun S Karlamangla
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

7.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

8.  Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids.

Authors:  Peter Vestergaard; Lars Rejnmark; Leif Mosekilde
Journal:  Chest       Date:  2007-09-21       Impact factor: 9.410

9.  The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008.

Authors:  Kerry Schnell; Carlos O Weiss; Todd Lee; Jerry A Krishnan; Bruce Leff; Jennifer L Wolff; Cynthia Boyd
Journal:  BMC Pulm Med       Date:  2012-07-09       Impact factor: 3.317

10.  C-reactive protein and fracture risk: European prospective investigation into Cancer Norfolk Study.

Authors:  Sara Ahmadi-Abhari; Robert N Luben; Nicholas J Wareham; Kay-Tee Khaw
Journal:  Bone       Date:  2013-05-20       Impact factor: 4.398

View more
  7 in total

1.  The Trabecular Bone Score as a Predictor for Thalassemia-Induced Vertebral Fractures in Northeastern Thailand.

Authors:  Nattiya Teawtrakul; Sukanya Chukanhom; Suranut Charoensri; Charoonsak Somboonporn; Chatlert Pongchaiyakul
Journal:  Anemia       Date:  2020-07-21

2.  Associations between bone mineral density and chronic obstructive pulmonary disease.

Authors:  Xiaodiao Zhang; Keke Ding; Xiaqi Miao; Jianing Wang; Binbin Hu; Jiamin Shen; Xueting Hu; Yage Xu; Beibei Yu; Tingting Tu; Aiju Lin; Xianjing Chen; Yiben Huang
Journal:  J Int Med Res       Date:  2022-05       Impact factor: 1.573

3.  Differences in bone density on chest CT according to smoking status in males without chronic obstructive lung disease.

Authors:  Cherry Kim; Soriul Kim; Ki Yeol Lee; Nan Hee Kim; Eun-Young Kang; Yu-Whan Oh; Chol Shin
Journal:  Sci Rep       Date:  2019-09-02       Impact factor: 4.379

4.  [Osteoporosis in pneumological diseases : Joint guideline of the Austrian Society for Bone and Mineral Research (ÖGKM) and the Austrian Society for Pneumology (ÖGP)].

Authors:  Christian Muschitz; Ralf Harun Zwick; Judith Haschka; Hans Peter Dimai; Martina Rauner; Karin Amrein; Robert Wakolbinger; Peter Jaksch; Ernst Eber; Peter Pietschmann
Journal:  Wien Klin Wochenschr       Date:  2021-06-16       Impact factor: 1.704

5.  Trabecular bone score in active or former smokers with and without COPD.

Authors:  Jessica González; Macarena Rodríguez-Fraile; Pilar Rivera; Patricia Restituto; Inmaculada Colina; María de Los Desamparados Calleja; Ana B Alcaide; Aránzazu Campo; Juan Bertó; Luís M Seijo; Teresa Pérez; Javier Zulueta; Nerea Varo; Juan P de-Torres
Journal:  PLoS One       Date:  2019-02-01       Impact factor: 3.240

6.  "Inflammaging" and bone in the OsteoLaus cohort.

Authors:  Jessica Fischer; Didier Hans; Olivier Lamy; Pedro Marques-Vidal; Peter Vollenweider; Bérengère Aubry-Rozier
Journal:  Immun Ageing       Date:  2020-03-05       Impact factor: 6.400

7.  Bone Mineral Density Compared to Trabecular Bone Score in Primary Hyperparathyroidism.

Authors:  Alicia R Jones; Koen Simons; Susan Harvey; Vivian Grill
Journal:  J Clin Med       Date:  2022-01-10       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.